Department of Pharmacology, Hôpital Européen Georges Pompidou, INSERM U970, Université Paris Descartes, Paris, France.
J Hypertens. 2012 Jun;30 Suppl:S3-8. doi: 10.1097/HJH.0b013e328353e501.
Whereas vascular aging has been identified as an emerging cardiovascular risk factor, definitions of 'normal' and 'early' vascular aging (EVA) and their precise relationship with cardiovascular risk are currently equivocal. The present review discusses the concept of vascular aging; that structural and functional changes occur in the large arteries with aging; and EVA; that such age-associated changes are accelerated in individuals at increased cardiovascular risk; and their metrics; indeed, in order to provide a definition of when EVA occurs in clinical practice, reference values of normal and accelerated vascular aging are needed. Due to the complex nature of age-associated changes in the large arteries described above, there are different parameters relating to vascular aging which can be measured. These broadly include aortic and carotid stiffening; aortic and carotid lumen dilation; endothelial dysfunction (usually measured via brachial flow-mediated dilatation); and carotid intima-media thickness.
虽然血管老化已被确定为一个新的心血管危险因素,但“正常”和“早期”血管老化(EVA)的定义及其与心血管风险的确切关系目前尚无定论。本综述讨论了血管老化的概念;即随着年龄的增长,大动脉的结构和功能会发生变化;以及 EVA;即这种与年龄相关的变化在心血管风险增加的个体中加速;以及它们的度量;实际上,为了在临床实践中提供 EVA 发生的定义,需要正常和加速血管老化的参考值。由于上述大动脉与年龄相关的变化的复杂性,有不同的参数与血管老化有关,可以测量。这些参数广泛包括主动脉和颈动脉僵硬度;主动脉和颈动脉管腔扩张;内皮功能障碍(通常通过肱动脉血流介导的扩张来测量);以及颈动脉内膜中层厚度。